PetVivo Holdings, Inc. (PETV)
OTCMKTS · Delayed Price · Currency is USD
0.9000
+0.0310 (3.57%)
Sep 12, 2025, 3:58 PM EDT
PetVivo Holdings Market Cap
PetVivo Holdings has a market cap or net worth of $25.11 million as of September 12, 2025. Its market cap has increased by 123.34% in one year.
Market Cap
25.11M
Enterprise Value
23.24M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.90
Market Cap Chart
Since March 25, 2014, PetVivo Holdings's market cap has decreased from 142.54M to 25.11M, a decrease of -82.38%. That is a compound annual growth rate of -14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 25.11M | 96.30% |
| Dec 31, 2024 | 12.79M | -16.58% |
| Dec 29, 2023 | 15.34M | -22.49% |
| Dec 30, 2022 | 19.79M | -46.07% |
| Dec 31, 2021 | 36.69M | -58.79% |
| Dec 31, 2020 | 89.02M | 711.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.52M |